Canntrust Holdings Inc.

TRST-T

Analysis and Opinions about TRST-T

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
September 25, 2019
(A Top Pick Oct 04/18, Down 87%) A perfect example on staying atop your stocks. He sold around $9.88. Never fund to sell on a loss, and he did and that saved a lot of money.
Show full opinionHide full opinion
(A Top Pick Oct 04/18, Down 87%) A perfect example on staying atop your stocks. He sold around $9.88. Never fund to sell on a loss, and he did and that saved a lot of money.
COMMENT
COMMENT
August 9, 2019
It's been a volatile day with the price falling in the morning following auditors withdrawing endorsement of its 2018 statement. The stock rallied near closing. A surprise that the stock rose so much at the end of the day. Somebody thinks they know something.
Show full opinionHide full opinion
It's been a volatile day with the price falling in the morning following auditors withdrawing endorsement of its 2018 statement. The stock rallied near closing. A surprise that the stock rose so much at the end of the day. Somebody thinks they know something.
COMMENT
COMMENT
July 24, 2019
He thinks there could be very serious legal ramifications for the management team if allegations prove to be true. He worries this may be going on in other companies as well. He thinks the lack of involvement in the space by Indigenous interests may also become an issue in the future.
Show full opinionHide full opinion
He thinks there could be very serious legal ramifications for the management team if allegations prove to be true. He worries this may be going on in other companies as well. He thinks the lack of involvement in the space by Indigenous interests may also become an issue in the future.
SELL
SELL
July 15, 2019
Caught hiding illegal cannabis from Health Canada has shaken market faith. Sell? There's never one cockroach, so there may be troubles at other pot companies. Sell this and maybe buy it back when there is clarity. TRST could lose their license. They have lost credibility among analysts. When bad things happen, they last not for a week, but months.
Show full opinionHide full opinion
Caught hiding illegal cannabis from Health Canada has shaken market faith. Sell? There's never one cockroach, so there may be troubles at other pot companies. Sell this and maybe buy it back when there is clarity. TRST could lose their license. They have lost credibility among analysts. When bad things happen, they last not for a week, but months.
BUY
BUY
February 4, 2019
He started researching the cannabis sector because he thought cannabis was a pump-and-dump play--and it's largely true. The ones who'll make lasting money in this space are the insiders who sold stock and their investment bankers. He's owned TRST the past 9 months. Research said that TRST tells the truth and is well-financed, and a low-cost operator with modern operations. Yes, it's been frustrating because TRST tells the truth and they do what they say they'll do. They're about to list in New York, but keep in mind who their investment bankers will be. This listing will attract Canadian coverage from banks, as well as from BAC and GS in the U.S. This will raise their profile and shareholder base a lot. A well-run company that wants to build sustainably for the long run.
Show full opinionHide full opinion
He started researching the cannabis sector because he thought cannabis was a pump-and-dump play--and it's largely true. The ones who'll make lasting money in this space are the insiders who sold stock and their investment bankers. He's owned TRST the past 9 months. Research said that TRST tells the truth and is well-financed, and a low-cost operator with modern operations. Yes, it's been frustrating because TRST tells the truth and they do what they say they'll do. They're about to list in New York, but keep in mind who their investment bankers will be. This listing will attract Canadian coverage from banks, as well as from BAC and GS in the U.S. This will raise their profile and shareholder base a lot. A well-run company that wants to build sustainably for the long run.
HOLD
HOLD
January 30, 2019
They are working on a US listing. It is a cannabis stock that is hoping to get better US multiples. He thinks they might be taken out going forward. They have international expansion and are growing in Canada. They trade at a discount to the larger peer group in the space. He owns it and thinks it goes higher.
Show full opinionHide full opinion
They are working on a US listing. It is a cannabis stock that is hoping to get better US multiples. He thinks they might be taken out going forward. They have international expansion and are growing in Canada. They trade at a discount to the larger peer group in the space. He owns it and thinks it goes higher.
WATCH
WATCH
December 13, 2018
Frustrated by it. Still owns it. When they bought it they thought that they had a solid business case. They just hired a new CEO. The Member of the Board continue to sell stocks and that is not a good sign but the profits and financials are very strong. He thinks there are going to be joint ventures in the US and internationally. They reported real revenue growth. The company needs to make changes at the Board level.
Show full opinionHide full opinion
Frustrated by it. Still owns it. When they bought it they thought that they had a solid business case. They just hired a new CEO. The Member of the Board continue to sell stocks and that is not a good sign but the profits and financials are very strong. He thinks there are going to be joint ventures in the US and internationally. They reported real revenue growth. The company needs to make changes at the Board level.
BUY
BUY
December 12, 2018
A past top pick. From a pure valuation perspective he likes it and it trades at 7 times EBITA compared to competitors that trade at 30 times. They have taken a medical approch to their company and have a distribution agreement into Germany. They are involved in a brew-buds technology for the US. He is surprised of the recent sell off and attributes it to the delay in getting a US listing. He owns it and still likes it.
Show full opinionHide full opinion
A past top pick. From a pure valuation perspective he likes it and it trades at 7 times EBITA compared to competitors that trade at 30 times. They have taken a medical approch to their company and have a distribution agreement into Germany. They are involved in a brew-buds technology for the US. He is surprised of the recent sell off and attributes it to the delay in getting a US listing. He owns it and still likes it.
TOP PICK
TOP PICK
October 17, 2018

This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries. They win 38% of new patients added to new medical cannabis users. They hire doctors to educate doctors about medical usages. Yield 0%. (Analysts’ price target is $16.93)

Show full opinionHide full opinion

This company was founded by pharmacists who is globally focused in generic drug manufacturing in 115 countries. They win 38% of new patients added to new medical cannabis users. They hire doctors to educate doctors about medical usages. Yield 0%. (Analysts’ price target is $16.93)

TOP PICK
TOP PICK
October 4, 2018

They have done a great job. They are in the top three as far as medical patients go. It is super cheap. They are talking about a US listing and that could light it on fire. They could get taken over. (Analysts' target; $16.11).

Show full opinionHide full opinion

They have done a great job. They are in the top three as far as medical patients go. It is super cheap. They are talking about a US listing and that could light it on fire. They could get taken over. (Analysts' target; $16.11).

BUY
BUY
September 10, 2018

ACB-T vs. APH-T. The sector is highly volatile. APH-T is possibly a little higher quality and there have been rumours around them getting a large investment from a strategic player. TRST-T is the one he holds and is the best way to play this sector.

Show full opinionHide full opinion

ACB-T vs. APH-T. The sector is highly volatile. APH-T is possibly a little higher quality and there have been rumours around them getting a large investment from a strategic player. TRST-T is the one he holds and is the best way to play this sector.

COMMENT
COMMENT
May 15, 2018

This is a relatively small cannabis player but the trailing EBITDA is minimal and the forecasted earnings are speculative. He bought the IPO at $2 and sold it at $4. It’s one of the higher quality companies in the space, with interesting value add ideas. They even have a patent for infused cannabis in Keurig cups.

Show full opinionHide full opinion

This is a relatively small cannabis player but the trailing EBITDA is minimal and the forecasted earnings are speculative. He bought the IPO at $2 and sold it at $4. It’s one of the higher quality companies in the space, with interesting value add ideas. They even have a patent for infused cannabis in Keurig cups.

DON'T BUY
DON'T BUY
May 2, 2018

This is a cannabis company that has a new product line for pets. He generally dislikes the sector and the associated valuations. You are betting this sector is going to explode and it is hard to know which companies will survive. It has a $600 million valuation on $20 million in sales.

Show full opinionHide full opinion

This is a cannabis company that has a new product line for pets. He generally dislikes the sector and the associated valuations. You are betting this sector is going to explode and it is hard to know which companies will survive. It has a $600 million valuation on $20 million in sales.

Showing 1 to 13 of 13 entries
  • «
  • 1
  • »

Canntrust Holdings Inc.(TRST-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Canntrust Holdings Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Canntrust Holdings Inc.(TRST-T) Frequently Asked Questions

What is Canntrust Holdings Inc. stock symbol?

Canntrust Holdings Inc. is a Canadian stock, trading under the symbol TRST-T on the Toronto Stock Exchange (TRST-CT). It is usually referred to as TSX:TRST or TRST-T

Is Canntrust Holdings Inc. a buy or a sell?

In the last year, 2 stock analysts published opinions about TRST-T. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Canntrust Holdings Inc..

Is Canntrust Holdings Inc. a good investment or a top pick?

Canntrust Holdings Inc. was recommended as a Top Pick by Bruce Campbell (2) on 2019-09-25. Read the latest stock experts ratings for Canntrust Holdings Inc..

Why is Canntrust Holdings Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Canntrust Holdings Inc. worth watching?

2 stock analysts on Stockchase covered Canntrust Holdings Inc. In the last year. It is a trending stock that is worth watching.

What is Canntrust Holdings Inc. stock price?

On 2020-05-06, Canntrust Holdings Inc. (TRST-T) stock closed at a price of $0.91.